Skip to main content
. 2022 Apr 29;13:790608. doi: 10.3389/fimmu.2022.790608

Figure 9.

Figure 9

Prediction of ADAMTS14-related immune responses of immunotherapy in ccRCC patients. (A) Distribution of ADAMTS14 expression in pan-cancer immune subtypes in TCGA dataset. (B) Distribution of ADAMTS14 expression in CTLA4 scores by TCIA dataset. (C) Distribution of ADAMTS14 expression in TIDE scores by TIDE dataset. (D) Distribution of ADAMTS14 expression in T-cell dysfunction scores by TIDE dataset. (E) Distribution of ADAMTS14 expression in MSI scores by TIDE dataset. ***p < 0.001.